260 related articles for article (PubMed ID: 12213404)
1. Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines.
Joseph A; Louria-Hayon I; Plis-Finarov A; Zeira E; Zakay-Rones Z; Raz E; Hayashi T; Takabayashi K; Barenholz Y; Kedar E
Vaccine; 2002 Sep; 20(27-28):3342-54. PubMed ID: 12213404
[TBL] [Abstract][Full Text] [Related]
2. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561
[TBL] [Abstract][Full Text] [Related]
3. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.
McCluskie MJ; Weeratna RD; Davis HL
Vaccine; 2001 Mar; 19(17-19):2657-60. PubMed ID: 11257405
[TBL] [Abstract][Full Text] [Related]
4. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
5. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants.
McCluskie MJ; Davis HL
Vaccine; 2000 Oct; 19(4-5):413-22. PubMed ID: 11027803
[TBL] [Abstract][Full Text] [Related]
6. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1239-50. PubMed ID: 10195637
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
[TBL] [Abstract][Full Text] [Related]
8. Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines.
van Slooten ML; Hayon I; Babai I; Zakay-Rones Z; Wagner E; Storm G; Kedar E
Biochim Biophys Acta; 2001 Mar; 1531(1-2):99-110. PubMed ID: 11278176
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
10. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
11. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
McCluskie MJ; Davis HL
J Immunol; 1998 Nov; 161(9):4463-6. PubMed ID: 9794366
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory DNA is a potent mucosal adjuvant.
Horner AA; Ronaghy A; Cheng PM; Nguyen MD; Cho HJ; Broide D; Raz E
Cell Immunol; 1998 Nov; 190(1):77-82. PubMed ID: 9826449
[TBL] [Abstract][Full Text] [Related]
13. A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.
Asanuma H; Zamri NB; Sekine S; Fukuyama Y; Tokuhara D; Gilbert RS; Fukuiwa T; Fujihashi K; Sata T; Tashiro M; Fujihashi K
Vaccine; 2012 Jan; 30(4):803-12. PubMed ID: 22100889
[TBL] [Abstract][Full Text] [Related]
14. Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice.
Madhun AS; Haaheim LR; Nøstbakken JK; Ebensen T; Chichester J; Yusibov V; Guzman CA; Cox RJ
Vaccine; 2011 Jul; 29(31):4973-82. PubMed ID: 21600260
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
McCluskie MJ; Weeratna RD; Davis HL
Mol Med; 2000 Oct; 6(10):867-77. PubMed ID: 11126201
[TBL] [Abstract][Full Text] [Related]
16. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
17. Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens.
Fu J; Liang J; Kang H; Lin J; Yu Q; Yang Q
Poult Sci; 2013 Nov; 92(11):2866-75. PubMed ID: 24135589
[TBL] [Abstract][Full Text] [Related]
18. Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels.
Reidel IG; Curti CC; Dorémus L; Béré E; Delwail A; Russi RC; Lecron JC; Morel F; García MI; Müller DM; Jégou JF; Veaute CM
Vaccine; 2024 Mar; 42(8):1953-1965. PubMed ID: 38378388
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
20. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
